Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,594 | -48,122 | -20,894 | -54,217 | -37,915 |
| Depreciation Amortization | 44 | 28 | 14 | 313 | 300 |
| Accounts receivable | -1,550 | -1,190 | -503 | -458 | -461 |
| Accounts payable and accrued liabilities | -1,026 | -509 | -92 | 4,213 | 3,535 |
| Other Working Capital | 337 | 1,098 | 878 | 3,419 | 3,442 |
| Other Operating Activity | 7,353 | 4,698 | 1,448 | 1,210 | 864 |
| Operating Cash Flow | $-62,435 | $-43,997 | $-19,150 | $-45,521 | $-30,236 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -16 | N/A | -31 | -31 |
| Purchase Sale Intangibles | -118 | -79 | -37 | -587 | -193 |
| Other Investing Activity | -118 | -79 | -37 | -576 | -193 |
| Investing Cash Flow | $-134 | $-94 | $-37 | $-607 | $-224 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 92,331 | 59,975 | 59,483 | 43,298 | 43,268 |
| Financing Cash Flow | $92,331 | $59,975 | $59,483 | $43,298 | $43,268 |
| Beginning Cash Position | 51,362 | 51,362 | 51,362 | 54,191 | 54,191 |
| End Cash Position | 81,124 | 67,246 | 91,659 | 51,362 | 66,999 |
| Net Cash Flow | $29,762 | $15,884 | $40,297 | $-2,830 | $12,808 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,435 | -43,997 | -19,150 | -45,521 | -30,236 |
| Capital Expenditure | -16 | -16 | N/A | -31 | -31 |
| Free Cash Flow | -62,450 | -44,012 | -19,150 | -45,552 | -30,267 |